Current pathology practices in and barriers to MDS diagnosis

Leukemia Research

Volumn 37, Issue 12, 2013, Pages 1656-1661

  Glauser, Terry Ann ^a   Sagatys, Elizabeth M ^b   Williamson, J Chad ^a   Burton, B Stephen ^a   Berger, Christine ^c   Merwin, Patti ^c   Sugrue, Mary ^c   Bennett, John M ^d  

^a CE Outcomes   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c CELGENE CORPORATION   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute myeloid leukemia; Hematopathology; Myelodysplastic syndromes; Pathology; Physician practice patterns; Practice gaps

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER CLASSIFICATION; CANCER PROGNOSIS; CLINICAL PRACTICE; CYTOGENETICS; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PATHOLOGIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; UNITED STATES;

EID: 84888136734     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.10.007     Document Type: Article

References (18)

1. Hellström-Lindberg E. Myelodysplastic syndromes 2008, Remedica, London.
2. List A.F., Vardiman J., Issa J.J., DeWitte T.M. Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 2004, 297-317.
3. Komrokji R., Zhang L., Bennett J.M. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin North Am 2010, 24(2):443-457. [NCCN Clinical Practice Guidelines in Oncology. Myelodysplastic Syndromes. Version 2. 2013].
4. Bennett J.M., Komrokji R., Kouides P.A. The myelodysplastic syndromes. Clinical oncology 2008, Churchill Livingstone, Philadelphia. 4th ed. M.D. Abeloff, J.O. Armitage, J.E. Neiderhuber, M.B. Kastan, W.G. McKenna (Eds.).
5. CAP Cancer Protocols and Checklists - Hematologic - Bone Marrow 2012, http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/BoneMarrow_11protocol.pdf [accessed 19.04.12].
6. Mufti G.J., Bennett J.M., Goasguen J., et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008, 93(11):1712-1717.
7. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982, 51(2):189-199.
8. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100(7):2292-2302.
9. Vardiman J.W., Thiele J., Arber D.A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114(5):937-951.
10. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in MDS. Blood 1997, 89(6):2079-2088.
11. Greenberg P.L., Tuechler H., Schanz J., et al. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 2012, [Prepublished on June 27, 2012]. 10.1182/blood-2012-03-420489.
12. Malcovati L., Porta M.G., Pascutto C., et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007, 25(23):3503-3510.
13. Fey M.F., Dreyling M. ESMO Guidelines Working Group. Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl 5):v158-v161.
14. Kantarjian H., O'Brien S., Ravandi F., et al. The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?. Cancer 2009, 115(22):5202-5209.
15. Naqvi K., Jabbour E., Bueso-Ramos C., et al. Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. Blood 2011, 118(17):4690-4693.
16. Lee S.-H., Erber W.N., Porwit A., Tomonaga M., Peterson L.C. ICSH guidelines for the standardization of bone marrow specimens and reports. Int J Lab Hematol 2008, 30:349-364. For the International Council for Standardization in Hematology.
17. Senent L., Arenillas L., Luno E., Ruiz J.C., Sanz G., Florensa L. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes. Haematologica 2013, 98(4):568-575.
18. Peabody J.W., Luck J., Glassman P., et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 2004, 141(10):771-780.